Home › Funds › EMINENCE CAPITAL, LP › THC
EMINENCE CAPITAL, LP position in THC
TENET HEALTHCARE CORP · Health Care
EMINENCE CAPITAL, LP reported holding 790,302 shares of THC (TENET HEALTHCARE CORP) in its Q1 2026 13F filing — a position valued at US$149.1M, representing 3.42% of its reported portfolio and ranking #13 among its reported holdings. EMINENCE CAPITAL, LP has disclosed THC holdings in 3 of the last 3 reported quarters, going back to Q3 2025.
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
How EMINENCE CAPITAL, LP's THC position evolved
EMINENCE CAPITAL, LP first disclosed a stake in THC in Q3 2025 at 1,109,450 shares (US$225.3M). Across 3 filings, EMINENCE CAPITAL, LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q1 2026) shows 790,302 shares valued at US$149.1M — an increase of 176,341 shares quarter over quarter.. Notable position changes include a 45% trim in Q4 2025 (shares fell 5% over the following quarter), a 29% increase in Q1 2026 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 1.11M | $225.26M | New |
| Q4 2025 | 613.96K | $122.01M | Reduce |
| Q1 2026 | 790.30K | $149.14M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About THC and 13F data
THC (TENET HEALTHCARE CORP) is a Health Care company. 39 other funds we track also report a position in THC — the largest reported positions include Boston Partners (US$829.1M), GLENVIEW CAPITAL MANAGEMENT, LLC (US$418.2M), MANNING & NAPIER ADVISORS LLC (US$168.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding THC
- Boston Partners 4.43M sh · $829.06M · Q2 2026
- GLENVIEW CAPITAL MANAGEMENT, LLC 2.24M sh · $418.25M · Q2 2026
- MANNING & NAPIER ADVISORS LLC 901.64K sh · $168.76M · Q2 2026
More on EMINENCE CAPITAL, LP
FAQ
How long has EMINENCE CAPITAL, LP held THC?
EMINENCE CAPITAL, LP has disclosed THC holdings in 3 of the last 3 reported quarters, going back to Q3 2025.
What is EMINENCE CAPITAL, LP's current position in THC?
As of Q1 2026, EMINENCE CAPITAL, LP holds 790.30K shares of THC (TENET HEALTHCARE CORP), valued at $149.14M, representing 3.42% of its reported portfolio and ranking #13.
Has EMINENCE CAPITAL, LP been buying or selling THC?
In the latest 13F filing (Q1 2026), EMINENCE CAPITAL, LP increased its position in THC.
Which other funds hold THC?
Other major institutional holders of THC include Boston Partners, GLENVIEW CAPITAL MANAGEMENT, LLC, MANNING & NAPIER ADVISORS LLC, among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.